Mitra Biotech

Mitra Biotech is a global leader in advancing personalised oncology treatment and supporting more effective and efficient cancer drug development. Founded in 2010, Mitra is headquartered in Greater Boston and maintains a significant research and laboratory presence in Bengaluru, India.

Our unique CANscript™ platform delivers powerful, individualised treatment response predictions — with exceptionally high correlation to clinical outcomes — to inform patient-specific cancer treatment selection and enhance drug discovery.

Transforming translational research: CANscript^TM – a better predictive model for oncology

Transforming translational research: CANscript^TM – A better predictive model for oncology